Cardea Bio Appoints Genomics Industry Veteran Dawn Barry to its Board of Directors
Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors. Dawn Barry is the President & co-founder of LunaPBC, Inc., which was named by the World Economic Forum as a Technology Pioneer in 2019.
Cardea technology taps into biology's internal communication to expand or replace current optical and static measurements with interactive live streams of multi-omic signals and analyses. Graphene, a biocompatible nanomaterial, is a near perfect conductor as it is only one atom thick, and Cardea has patented uses of this material to gain a signal resolution high enough to listen into real-time molecular interactions.